J

Japan Tissue Engineering Co Ltd
TSE:7774

Watchlist Manager
Japan Tissue Engineering Co Ltd
TSE:7774
Watchlist
Price: 435 JPY -3.33% Market Closed
Market Cap: 17.7B JPY
Have any thoughts about
Japan Tissue Engineering Co Ltd?
Write Note

Japan Tissue Engineering Co Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Japan Tissue Engineering Co Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
J
Japan Tissue Engineering Co Ltd
TSE:7774
Cash & Cash Equivalents
ÂĄ4B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
13%
GNI Group Ltd
TSE:2160
Cash & Cash Equivalents
ÂĄ14B
CAGR 3-Years
0%
CAGR 5-Years
14%
CAGR 10-Years
11%
PeptiDream Inc
TSE:4587
Cash & Cash Equivalents
ÂĄ50.4B
CAGR 3-Years
60%
CAGR 5-Years
43%
CAGR 10-Years
31%
Takara Bio Inc
TSE:4974
Cash & Cash Equivalents
ÂĄ40B
CAGR 3-Years
7%
CAGR 5-Years
17%
CAGR 10-Years
8%
Pharma Foods International Co Ltd
TSE:2929
Cash & Cash Equivalents
ÂĄ11.8B
CAGR 3-Years
2%
CAGR 5-Years
27%
CAGR 10-Years
22%
C
Cuorips Inc
TSE:4894
Cash & Cash Equivalents
ÂĄ5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Japan Tissue Engineering Co Ltd
Glance View

Market Cap
17.7B JPY
Industry
Biotechnology

Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.

Intrinsic Value
376.39 JPY
Overvaluation 13%
Intrinsic Value
Price
J

See Also

What is Japan Tissue Engineering Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
4B JPY

Based on the financial report for Sep 30, 2024, Japan Tissue Engineering Co Ltd's Cash & Cash Equivalents amounts to 4B JPY.

What is Japan Tissue Engineering Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
13%

Over the last year, the Cash & Cash Equivalents growth was -4%. The average annual Cash & Cash Equivalents growth rates for Japan Tissue Engineering Co Ltd have been -8% over the past three years , -7% over the past five years , and 13% over the past ten years .

Back to Top